12:00 AM
Jul 02, 2012
 |  BC Week In Review  |  Company News  |  Deals

Corimmun, J&J deal

Johnson & Johnson's Janssen-Cilag GmbH unit acquired CorImmun for an upfront payment and milestones. CorImmun's

Read the full 63 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >